NasdaqGS:PODD
NasdaqGS:PODDMedical Equipment

Is Insulet Fairly Priced After Its Strong Run and High Earnings Multiple in 2025?

If you are looking at Insulet and wondering whether the recent price makes it a buy, hold, or avoid, you are not alone. This stock often divides opinion among growth focused investors. After a strong run to around $289.62, the shares are still up 12.8% year to date and 10.0% over the last year, even though the stock has slipped 0.6% in the past week and 12.5% over the past month and remains roughly flat over 3 years while still compounding at 13.2% over 5 years. Recent attention has centred...
NasdaqGM:ORKA
NasdaqGM:ORKABiotechs

Oruka Therapeutics (ORKA): Valuation Check After Board Appointment of Commercial Veteran Chris Martin

Oruka Therapeutics (ORKA) shares have been moving after the company added Chris Martin to its board, a commercial veteran whose launch and M&A track record could reshape how investors think about Oruka’s pipeline. See our latest analysis for Oruka Therapeutics. The market seems to be buying into that narrative already, with a 1 day share price return of 13.11% and a 90 day share price return of 104.63%. The 1 year total shareholder return of 51.62% suggests momentum has been building rather...
NYSE:CLVT
NYSE:CLVTProfessional Services

Does Morgan Stanley’s Downgrade and Nissan Win Reframe Clarivate’s (CLVT) Competitive Moat in the AI Era?

Morgan Stanley previously downgraded Clarivate Plc to Underweight, citing a prolonged turnaround, muted growth expectations, limited operating leverage, and intensifying competitive pressures from AI-enabled rivals. At the same time, Clarivate’s new role supporting Nissan’s IP management highlights how its workflow tools remain embedded in large-scale innovation ecosystems despite these challenges. We’ll now examine how Morgan Stanley’s concerns about Clarivate’s turnaround and AI...
NYSE:SYY
NYSE:SYYConsumer Retailing

Sysco (SYY): Reassessing Valuation After New Four-Year Teamsters Labor Deal Reshapes Costs and Stability

Sysco (SYY) just locked in a four year labor deal with the Teamsters for more than 1,000 drivers and warehouse workers, bringing 34% wage increases and richer benefits that could reshape its cost and risk profile. See our latest analysis for Sysco. Despite solid earnings growth, Sysco’s recent 90 day share price return of negative 9.4 percent shows momentum has cooled, even though its five year total shareholder return of 14.7 percent remains positive and points to steady long term...
NasdaqGS:AFYA
NasdaqGS:AFYAConsumer Services

Assessing Afya (NasdaqGS:AFYA)’s Valuation After a 3-Month Share Price Pullback

Afya (NasdaqGS:AFYA) has been drifting lower again, extending a weak past 3 months that leaves the stock down about 10%, even as revenue and net income keep growing at a solid clip. See our latest analysis for Afya. Over the past year, Afya’s total shareholder return of roughly negative 5% and a weaker 5 year total shareholder return of about negative 41% suggest momentum has been fading, as investors reassess growth prospects and Brazil specific risks despite ongoing earnings progress. If...
NasdaqGS:MRCY
NasdaqGS:MRCYAerospace & Defense

Mercury Systems (MRCY): Reassessing Valuation After Earnings Beat and Defense Demand Tailwinds

Mercury Systems (MRCY) is back in focus after Aristotle Capital Boston called out the stock as a recent winner in its small cap fund, helped by earnings that topped expectations and strengthening defense demand. See our latest analysis for Mercury Systems. At around $69.65, Mercury’s share price has pulled back over the last week but still sits on a hefty year to date share price return. A 1 year total shareholder return above 70 percent signals that optimism around defense demand and its...
NYSE:MRK
NYSE:MRKPharmaceuticals

What Merck (MRK)'s Diabetes Price Cuts and Oncology Advances Mean For Shareholders

Earlier this month, Merck reached a historic agreement with the Trump administration to sharply cut U.S. prices on several medicines, including offering JANUVIA, JANUMET and JANUMET XR to eligible patients through a direct-to-patient program at roughly 70% below current list prices, while also reporting positive Phase 3 results for KEYTRUDA plus Padcev in muscle-invasive bladder cancer. Alongside this pricing shift, Merck is advancing enlicitide, an oral PCSK9-like cholesterol candidate, and...
NasdaqGS:TRIN
NasdaqGS:TRINCapital Markets

Trinity Capital’s Shift To Monthly Dividends Raises New Questions About Its Income Strategy (TRIN)

Trinity Capital Inc. recently announced it will shift from quarterly to monthly dividends starting January 2026, with the Board approving regular monthly payouts of US$0.17 per share for January, February, and March 2026, alongside a US$0.51 per-share cash dividend for the fourth quarter of 2025 payable on 15 January 2026. This move preserves an equivalent total payout of US$0.51 per quarter, extends Trinity’s record to 25 consecutive quarters of consistent or higher distributions, and may...
NYSE:TPC
NYSE:TPCConstruction

What Tutor Perini (TPC)'s New US$900 Million Corps Contract Means For Shareholders

Tutor Perini, through subsidiaries Rudolph and Sletten and Perini Management Services, recently secured multiple large contracts, including a US$900 million U.S. Army Corps of Engineers agreement in Israel, a US$155 million Diego Rivera Performing Arts Center project in San Francisco, and a US$108 million UC Davis Health utility plant expansion. These awards meaningfully enlarge Tutor Perini’s backlog and reinforce its access to complex institutional and government work, which can improve...
AIM:ADVT
AIM:ADVTSoftware

3 UK Penny Stocks With Market Caps Under £600M

The UK market has recently faced challenges, with the FTSE 100 index experiencing declines due to weak trade data from China, highlighting global economic interdependencies. In such fluctuating conditions, identifying stocks with strong financials becomes crucial for investors seeking stability and potential growth. Penny stocks, though an older term, still represent opportunities in smaller or newer companies that may offer value and growth potential despite their lower price points.
SEHK:1308
SEHK:1308Shipping

Assessing SITC International Holdings (SEHK:1308) Valuation After Its Confidence-Boosting Special Dividend Announcement

SITC International Holdings (SEHK:1308) has just declared a special cash dividend of HKD 0.70 per share, which is a clear signal that management is comfortable returning extra cash to shareholders on top of regular payouts. See our latest analysis for SITC International Holdings. The special dividend announcement comes after a strong run, with the share price at HK$27.74 and a robust year to date share price return. The one year total shareholder return of 58.02 percent suggests momentum is...
NYSE:AZO
NYSE:AZOSpecialty Retail

How Margin Squeeze From Rising Costs And LIFO Charges At AutoZone (AZO) Has Changed Its Investment Story

AutoZone, Inc. reported past first-quarter 2025 results with sales rising to US$4,628.63 million from US$4,279.64 million a year earlier, while net income fell to US$530.82 million and diluted EPS slipped to US$31.04 as margin pressures weighed on profitability. Management pointed to sizeable non-cash LIFO charges, higher store and supply-chain spending, and weather-related disruptions as key reasons why profit growth lagged solid top-line momentum. Next, we’ll examine how this margin...
NasdaqGS:PYPL
NasdaqGS:PYPLDiversified Financial

PayPal (PYPL): Assessing Valuation After Share Price Slide and Launch of PayPal World

PayPal Holdings (PYPL) has quietly drifted lower this year, even as its underlying business keeps growing revenue and earnings at mid single digit rates. That gap between sentiment and fundamentals is where the opportunity may sit. See our latest analysis for PayPal Holdings. The stock tells a different story to the business, with the share price sliding to about $59.81 and posting a year to date share price return of roughly negative 31 percent, alongside a similar one year total shareholder...
NasdaqGM:DJT
NasdaqGM:DJTInteractive Media and Services

Trump Media & Technology Group (DJT): Assessing Valuation After a Sharp 30-Day Rebound in the Share Price

Trump Media & Technology Group stock reaction Trump Media & Technology Group (DJT) has experienced significant volatility lately, with the stock rising about 54% over the past month after a deep slide earlier this year. See our latest analysis for Trump Media & Technology Group. Despite the sharp 7 day and 30 day share price returns, the stock is still heavily down on a year to date basis. This suggests that momentum is more of a speculative rebound than a steady rerating based on...
NasdaqGS:SLM
NasdaqGS:SLMConsumer Finance

Alleged Misleading Delinquency Disclosures Might Change The Case For Investing In SLM (SLM)

Robbins Geller Rudman & Dowd LLP has filed a class action lawsuit against SLM Corporation, alleging that between July 25 and August 14, 2025, the company and certain executives misled investors about rising early-stage loan delinquencies and the effectiveness of its loss mitigation and loan modification programs. The complaint directly contrasts SLM’s CFO’s late-July assurances about “normal” seasonal delinquency trends with later third-party data showing a sharp deterioration in early-stage...
NYSE:HXL
NYSE:HXLAerospace & Defense

Is Hexcel’s Role in Next‑Gen Airframes Reshaping the Long‑Term Investment Narrative for HXL?

Recently, investor commentary highlighted Hexcel’s role as a key supplier of carbon fiber composites to major airframers like Airbus and Boeing, pointing to easing supply chain bottlenecks and a possible ramp-up in aircraft production over the next few years. This renewed focus on Hexcel’s entrenched position in next-generation aircraft programs has amplified interest in how rising composite content could influence its long-term growth profile. We’ll now examine how expectations for...
NYSE:MCO
NYSE:MCOCapital Markets

Is It Too Late to Consider Moody's After Its 85% Three Year Rally?

Wondering if Moody's is still worth buying after its huge run, or if the easy money has already been made? First, let's frame where the stock sits today before we dive into the numbers. The shares have nudged higher recently, up about 3.2% over the last week, 4.9% over the past month, and roughly 6.4% year to date, adding to an impressive 85.0% gain over three years. Those moves come against a backdrop of steady demand for credit ratings and analytics as debt markets stay active and...